Brings broad expertise across market access, health economics, HTA, pricing and reimbursement, and RWE, with a strong scientific background in oncology. His PhD focused on pharmacoeconomic methods for estimating the cost-effectiveness and budget impact of cancer treatments in Finland, complemented by several scientific publications. His career spans industry, consultancy, and academia, including roles at Novartis, Bristol Myers Squibb, and Medfiles. He is also an Adjunct Professor of Pharmacoeconomics at the University of Eastern Finland.
Attending Masterclasses
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now